CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $96,000 | +209.7% | 3,866 | +208.8% | 0.00% | – |
| Q1 2022 | $31,000 | -78.2% | 1,252 | -67.9% | 0.00% | -100.0% |
| Q4 2021 | $142,000 | +136.7% | 3,904 | +10.9% | 0.00% | – |
| Q3 2021 | $60,000 | +33.3% | 3,519 | +5.2% | 0.00% | – |
| Q2 2021 | $45,000 | -71.3% | 3,344 | +9.1% | 0.00% | -100.0% |
| Q1 2021 | $157,000 | -16.9% | 3,065 | +0.5% | 0.00% | -33.3% |
| Q4 2020 | $189,000 | +1250.0% | 3,050 | +1120.0% | 0.00% | – |
| Q3 2020 | $14,000 | -92.1% | 250 | -91.8% | 0.00% | -100.0% |
| Q2 2020 | $177,000 | +33.1% | 3,050 | -11.6% | 0.00% | 0.0% |
| Q1 2020 | $133,000 | +392.6% | 3,450 | -13.8% | 0.00% | +200.0% |
| Q3 2019 | $27,000 | +42.1% | 4,000 | +100.0% | 0.00% | 0.0% |
| Q2 2019 | $19,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |